Total current assets Total assets Total current liabilities Total liabilities Total stockholders’ equity Balance Balance Total liabilities and stockholders’ equity Total operating expenses Loss from operations Total other income, net Loss before income tax expense Net loss Net loss Total comprehensive loss Total comprehensive loss for the year (in thousands) Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net cash used in operating activities Net cash used in investing activities Net cash provided by financing activities Net decrease in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Total Re-domiciliation and Business [Abstract] Ownership [Axis] Basis of Presentation and Summary of Significant Accounting Policies [Abstract] Prepaid Expenses and Other Current Assets [Abstract] Total prepaid expenses and other current assets Prepaid expenses and other assets Assets Pledged as Security for Short-Term Debt [Abstract] Schedule of Assets Pledged as Security for Short-Term Debt [Abstract] R&D Tax Incentive Receivable [Abstract] Schedule of R&D Tax Incentive Receivable [Abstract] Property, Plant and Equipment, Net [Abstract] Total property, plant and equipment, gross Total property, plant and equipment, net Property, plant and equipment, net Trade and Other Payables, Accrued Expenses and Other Current Liabilities [Abstract] Schedule of Trade and Other Payables, Accrued Expenses and Other Current Liabilities [Abstract] Total trade and other payables Trade and other payables Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Total Trade and other payables, accrued expenses and other current liabilities Leases [Abstract] Schedule of Lease Costs [Abstract] Schedule of Future Minimum Lease Payments [Abstract] Total minimum lease payments Commitments and Contingencies [Abstarct] Stockholder’s Equity/Issued Capital [Abstract] Stock-Based Payments [Abstract] Statement of Income Location, Balance [Axis] Numbers of Shares, Unvested and Outstanding Beginning Numbers of Shares, Unvested and Outstanding Ending Weighted Average Grant Date Fair Value, Unvested and Outstanding Beginning Weighted Average Grant Date Fair Value, Unvested and Outstanding Ending Schedule of Stock Options [Abstract] Number of Shares, Outstanding balance Weighted Average Exercise Price, Outstanding balance (in Dollars per share) Fair Value of Financial Instruments [Abstract] Measurement Input Type [Axis] Class of Warrant or Right [Axis] Fair Value Hierarchy and NAV [Axis] Financial Instrument [Axis] Debt [Abstract] Schedule of Debt [Abstract] Income Tax [Abstarct] Loss Per Share [Abstract] Schedule of Basic and Diluted Net Loss Per Share Attributable to Stockholders [Abstract] Related Party Transactions [Abstract] Assets Current assets: Cash and cash equivalents Assets pledged as security for short-term debt Research and Development (“R&D”) tax incentive receivable R&D tax incentive receivable Operating lease right-of-use assets Liabilities and stockholders’ equity Current liabilities: Current liabilities Short-term debt FC Credit – 14.5% Facility agreement due 2025 Operating lease liabilities, current Operating lease liabilities, non-current Long-term debt Warrant liabilities Convertible rights Commitments and contingencies (Note 8) Stockholders’ equity: Common Stock, $0.0001 par value per share – 100,000,000 shares authorized; 17,785,235 and 17,642,832 shares issued and outstanding at December 31, 2024 and June 30, 2024 respectively Common Stock, par value per share (in Dollars per share) Common stock, par value (in Dollars per share) Common stock, par value Common Stock, shares authorized Common stock, shares authorized Common Stock, shares issued Common Stock, shares outstanding Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at December 31, 2024 and June 30, 2024, respectively Preferred stock, par value per share (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Additional paid-in capital Accumulated deficit Foreign currency translation reserve Revenue from customers Operating expenses: Other income, net: R&D tax incentive Foreign exchange losses Interest income Change in fair value of convertible rights ELOC commitment fee Other comprehensive income/(loss): Currency translation adjustment, net of tax Net loss per share: Basic (in Dollars per share) Basic loss per share Net loss per share: diluted (in Dollars per share) Diluted loss per share Weighted average number of shares outstanding, basic (in Shares) - Weighted average number of Common Stock (number) Weighted average number of shares outstanding, diluted (in Shares) Stock-based compensation Share issuance Share issuance (in Shares) Shares issuances (in Shares) Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Non-cash expense of ELOC commitment Share-based compensation expense Change in fair value of warrant liabilities Change in fair value of warrant liabilities Warrant liability Change in fair value of convertible rights Non-cash interest expense Change in operating assets and liabilities: Assets pledged as securities for short-term debt Trade and other payables Cash flows from investing activities: Cash flows from financing activities: Proceeds received from facility agreement Proceeds from issuance of convertible debt Effect of exchange rate changes on cash and cash equivalents Non-cash investing and financing activities Research and development General and administrative Interest expense Income tax expense Unrealized loss on foreign currency remeasurement Prepaid expenses and other current assets R&D tax incentive Purchase of property, plant and equipment Repayment of facility agreement Debt issuance costs Issuance of ELOC warrants at initial fair value Issuance of convertible note warrants at initial fair value Issuance of conversion rights at initial fair value Common Stock Common Stock [Member] Additional paid-in capital Accumulated deficit Foreign currency translation reserve Re-domiciliation and Business Schedule of Condensed Consolidated Financial Statements Jurisdiction Basis of Presentation and Summary of Significant Accounting Policies Prepaid expenses and other current assets Schedule of Prepaid Expenses and Other Current Assets Prepayments GST recoverable Assets pledged as security for short-term debt Schedule of Assets Pledged as Security for Short-Term Debt R&D tax incentive receivable Schedule of R&D Tax Incentive Receivable Property, Plant and Equipment, net Schedule of Property, Plant and Equipment, Net Furniture, fittings and equipment Assets under construction Trade and other payables, accrued expenses and other current liabilities Schedule of Trade and Other Payables, Accrued Expenses and Other Current Liabilities Trade payables Contract liabilities Accrued expenses Employee leave entitlements Leases Schedule of Lease Costs Lease term (years) Weighted-average remaining lease term Discount rate Operating lease cost Operating lease liabilities Schedule of Future Minimum Lease Payments June 30, 2025 June 30, 2026 June 30, 2027 June 30, 2028 Less amount representing interest Total operating lease liabilities Commitments and contingencies Stockholder’s equity/Issued capital Stock-based payments Schedule of Stock-Based Payments Total stock-based compensation expense Schedule of Restricted Stock Activity Numbers of Shares, Granted Weighted Average Grant Date Fair Value, Granted Numbers of Shares, Vested